Cadence Capital Management’s ICU Medical ICUI Stock Holding History

Cadence Capital Management’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2,420	Closed	-$417K	–	693
2017 Q2	$417K	Hold	2,420	–	–	0.03%	544
2017 Q1	$370K	Hold	2,420	–	–	0.03%	572
2016 Q4	$357K	Sell	2,420 -4,150	-63%	-$601K	0.03%	577
2016 Q3	$830K	Hold	6,570	–	–	0.06%	364
2016 Q2	$741K	Buy	6,570 +820	+14%	+$85.1K	0.06%	370
2016 Q1	$599K	Buy	+5,750	New	+$550K	0.04%	431
2015 Q3	–	Sell	-14,010	Closed	-$1.34M	–	621
2015 Q2	$1.34M	Buy	14,010 +6,090	+77%	+$569K	0.07%	334
2015 Q1	$738K	Buy	+7,920	New	+$693K	0.05%	451

Other funds holding ICUI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cadence Capital Management's ICUI Position: Q3 2017 in Review

Cadence Capital Management sold out of ICU Medical (ICUI) in Q3 2017, closing a stake of 2,420 shares — an estimated $417K sold.

Cadence Capital Management first reported a position in ICUI in Q1 2015 and held it in 8 quarters. The position peaked at $1.34M in Q2 2015. 226 funds tracked by Wall St. Rank hold ICUI as of Q3 2017.

Cadence Capital Management reported no remaining ICU Medical position as of Q3 2017 after selling out during the quarter.
Cadence Capital Management sold 2,420 ICU Medical shares in Q3 2017, an estimated $417K.
Cadence Capital Management first reported a position in ICU Medical in Q1 2015 and held it in 8 quarters.
Cadence Capital Management's ICU Medical position peaked at $1.34M in Q2 2015.
226 funds tracked by Wall St. Rank held ICU Medical as of Q3 2017.

Based on Cadence Capital Management's 13F filing for Q3 2017, filed 9 Nov 2017.